Arsenic Trioxide
| Generic Name | Arsenic Trioxide |
|---|---|
| Brand Reference | Trisenox® |
| DIN | 02492768 |
| GTIN | 834324002781 |
| Strength | 1 mg / mL |
| Format | Vial |
| Pack Size | 10 |
| Therapeutic Class | Antineoplastic |
| Product Insert | Click Here |
| Product Monograph | Click Here |
Item Codes
| SteriMax: | ST-DS111 |
|---|---|
| McKesson: | 147897 |
| McMahon: | 10113378 |
Cytoprotective Sheath
Cytotoxic Notification
Latex Free Stopper
Preservative Free
| Provincial Formulary Coverage | ✓:Listed | P:Pending | I:Interchangeable Only |
|---|
| BC | AB | SK | MB | ON | QC | NB | PE | NS | NL |
|---|---|---|---|---|---|---|---|---|---|
| ✓ | ✓ | ✓ | N/A | ✓ | N/A | N/A | P | N/A | N/A |
Product Description
Arsenic Trioxide for Injection is indicated for induction of remission and consolidation in patients with acute promyelocytic leukemia (APL), which is refractory to or has relapsed from retinoid and anthracycline therapy, and whose APL is characterized by the presence of the t(15;17) translocation or promyelocytic leukemia-retinoic-acid-receptor alpha (PML-RARα) gene expression.